Global and United States Cell Regeneration Medicine Market Report & Forecast 2022-2028

• Description
• Table of Contents
• Table of Figures
• PDF Download

• Description
• Table of Contents
• Table of Figures
• PDF Download

Market Analysis and Insights: Global and United States Cell Regeneration Medicine Market
This report focuses on global and United States Cell Regeneration Medicine market, also covers the segmentation data of other regions in regional level and county level.

Due to the COVID-19 pandemic, the global Cell Regeneration Medicine market size is estimated to be worth US$  million in 2022 and is forecast to a readjusted size of US$  million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, Primary Cell-based Therapeutics accounting for % of the Cell Regeneration Medicine global market in 2021, is projected to value US$  million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Dermatology was the leading segment, accounting for over  percent market share in 2021, and altered to an  % CAGR throughout this forecast period.

In United States the Cell Regeneration Medicine market size is expected to grow from US$  million in 2021 to US$  million by 2028, at a CAGR of % during the forecast period 2022-2028.

Global Cell Regeneration Medicine Scope and Market Size
Cell Regeneration Medicine market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Cell Regeneration Medicine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Cell Regeneration Medicine market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type
    Primary Cell-based Therapeutics
    Stem Cell & Progenitor Cell-based Therapeutics
    Cell-based Immunotherapies
    Gene Therapies

Segment by Application
    Dermatology
    Musculoskeletal
    Immunology and Inflammation
    Oncology
    Cardiovascular
    Ophthalmology
    Other Therapeutic Categories

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        China Taiwan
        Indonesia
        Thailand
        Malaysia
    Latin America
        Mexico
        Brazil
        Argentina
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE

By Company
    Abbott
    Amgen Inc.
    Astellas Pharma, Inc.
    AstraZeneca plc
    Baxter International, Inc.
    Bayer AG
    Boehringer Ingelheim
    Bristol-Myers Squibb
    Corline Biomedical AB

 1 Study Coverage
    1.1 Cell Regeneration Medicine Revenue in Cell Regeneration Medicine Business (2017-2022) & (US$ Million) Introduction
    1.2 Global Cell Regeneration Medicine Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Cell Regeneration Medicine Market Size for the Year 2017-2028
        1.2.2 Global Cell Regeneration Medicine Market Size for the Year 2017-2028
    1.3 Cell Regeneration Medicine Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.3.1 The Market Share of United States Cell Regeneration Medicine in Global, 2017 VS 2022 VS 2028
        1.3.2 The Growth Rate of Cell Regeneration Medicine Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.4 Cell Regeneration Medicine Market Dynamics
        1.4.1 Cell Regeneration Medicine Industry Trends
        1.4.2 Cell Regeneration Medicine Market Drivers
        1.4.3 Cell Regeneration Medicine Market Challenges
        1.4.4 Cell Regeneration Medicine Market Restraints
    1.5 Study Objectives
    1.6 Years Considered

 2 Cell Regeneration Medicine by Type
    2.1 Cell Regeneration Medicine Market Segment by Type
        2.1.1 Primary Cell-based Therapeutics
        2.1.2 Stem Cell & Progenitor Cell-based Therapeutics
        2.1.3 Cell-based Immunotherapies
        2.1.4 Gene Therapies
    2.2 Global Cell Regeneration Medicine Market Size by Type (2017, 2022 & 2028)
    2.3 Global Cell Regeneration Medicine Market Size by Type (2017-2028)
    2.4 United States Cell Regeneration Medicine Market Size by Type (2017, 2022 & 2028)
    2.5 United States Cell Regeneration Medicine Market Size by Type (2017-2028)

 3 Cell Regeneration Medicine by Application
    3.1 Cell Regeneration Medicine Market Segment by Application
        3.1.1 Dermatology
        3.1.2 Musculoskeletal
        3.1.3 Immunology and Inflammation
        3.1.4 Oncology
        3.1.5 Cardiovascular
        3.1.6 Ophthalmology
        3.1.7 Other Therapeutic Categories
    3.2 Global Cell Regeneration Medicine Market Size by Application (2017, 2022 & 2028)
    3.3 Global Cell Regeneration Medicine Market Size by Application (2017-2028)
    3.4 United States Cell Regeneration Medicine Market Size by Application (2017, 2022 & 2028)
    3.5 United States Cell Regeneration Medicine Market Size by Application (2017-2028)

 4 Global Cell Regeneration Medicine Competitor Landscape by Company
    4.1 Global Cell Regeneration Medicine Market Size by Company
        4.1.1 Top Global Cell Regeneration Medicine Companies Ranked by Revenue (2021)
        4.1.2 Global Cell Regeneration Medicine Revenue by Player (2017-2022)
    4.2 Global Cell Regeneration Medicine Concentration Ratio (CR)
        4.2.1 Cell Regeneration Medicine Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Companies of Cell Regeneration Medicine in 2021
        4.2.3 Global Cell Regeneration Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Cell Regeneration Medicine Headquarters, Revenue in Cell Regeneration Medicine Business (2017-2022) & (US$ Million) Type
        4.3.1 Global Cell Regeneration Medicine Headquarters and Area Served
        4.3.2 Global Cell Regeneration Medicine Companies Revenue in Cell Regeneration Medicine Business (2017-2022) & (US$ Million) Type
        4.3.3 Date of International Companies Enter into Cell Regeneration Medicine Market
    4.4 Companies Mergers & Acquisitions, Expansion Plans
    4.5 United States Cell Regeneration Medicine Market Size by Company
        4.5.1 Top Cell Regeneration Medicine Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Cell Regeneration Medicine Revenue by Players (2020, 2021 & 2022)

 5 Global Cell Regeneration Medicine Market Size by Region
    5.1 Global Cell Regeneration Medicine Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Cell Regeneration Medicine Market Size by Region (2017-2028)
        5.2.1 Global Cell Regeneration Medicine Market Size by Region: 2017-2022
        5.2.2 Global Cell Regeneration Medicine Market Size by Region (2023-2028)

 6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Cell Regeneration Medicine Market Size YoY Growth 2017-2028
        6.1.2 North America Cell Regeneration Medicine Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 United States
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Cell Regeneration Medicine Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Cell Regeneration Medicine Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 China Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
    6.3 Europe
        6.3.1 Europe Cell Regeneration Medicine Market Size YoY Growth 2017-2028
        6.3.2 Europe Cell Regeneration Medicine Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Cell Regeneration Medicine Market Size YoY Growth 2017-2028
        6.4.2 Latin America Cell Regeneration Medicine Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Cell Regeneration Medicine Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Cell Regeneration Medicine Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 UAE

 7 Company Profiles
    7.1 Abbott
        7.1.1 Abbott Company Details
        7.1.2 Abbott Business Overview
        7.1.3 Abbott Cell Regeneration Medicine Introduction
        7.1.4 Abbott Revenue in Cell Regeneration Medicine Business (2017-2022)
        7.1.5 Abbott Recent Development
    7.2 Amgen Inc.
        7.2.1 Amgen Inc. Company Details
        7.2.2 Amgen Inc. Business Overview
        7.2.3 Amgen Inc. Cell Regeneration Medicine Introduction
        7.2.4 Amgen Inc. Revenue in Cell Regeneration Medicine Business (2017-2022)
        7.2.5 Amgen Inc. Recent Development
    7.3 Astellas Pharma, Inc.
        7.3.1 Astellas Pharma, Inc. Company Details
        7.3.2 Astellas Pharma, Inc. Business Overview
        7.3.3 Astellas Pharma, Inc. Cell Regeneration Medicine Introduction
        7.3.4 Astellas Pharma, Inc. Revenue in Cell Regeneration Medicine Business (2017-2022)
        7.3.5 Astellas Pharma, Inc. Recent Development
    7.4 AstraZeneca plc
        7.4.1 AstraZeneca plc Company Details
        7.4.2 AstraZeneca plc Business Overview
        7.4.3 AstraZeneca plc Cell Regeneration Medicine Introduction
        7.4.4 AstraZeneca plc Revenue in Cell Regeneration Medicine Business (2017-2022)
        7.4.5 AstraZeneca plc Recent Development
    7.5 Baxter International, Inc.
        7.5.1 Baxter International, Inc. Company Details
        7.5.2 Baxter International, Inc. Business Overview
        7.5.3 Baxter International, Inc. Cell Regeneration Medicine Introduction
        7.5.4 Baxter International, Inc. Revenue in Cell Regeneration Medicine Business (2017-2022)
        7.5.5 Baxter International, Inc. Recent Development
    7.6 Bayer AG
        7.6.1 Bayer AG Company Details
        7.6.2 Bayer AG Business Overview
        7.6.3 Bayer AG Cell Regeneration Medicine Introduction
        7.6.4 Bayer AG Revenue in Cell Regeneration Medicine Business (2017-2022)
        7.6.5 Bayer AG Recent Development
    7.7 Boehringer Ingelheim
        7.7.1 Boehringer Ingelheim Company Details
        7.7.2 Boehringer Ingelheim Business Overview
        7.7.3 Boehringer Ingelheim Cell Regeneration Medicine Introduction
        7.7.4 Boehringer Ingelheim Revenue in Cell Regeneration Medicine Business (2017-2022)
        7.7.5 Boehringer Ingelheim Recent Development
    7.8 Bristol-Myers Squibb
        7.8.1 Bristol-Myers Squibb Company Details
        7.8.2 Bristol-Myers Squibb Business Overview
        7.8.3 Bristol-Myers Squibb Cell Regeneration Medicine Introduction
        7.8.4 Bristol-Myers Squibb Revenue in Cell Regeneration Medicine Business (2017-2022)
        7.8.5 Bristol-Myers Squibb Recent Development
    7.9 Corline Biomedical AB
        7.9.1 Corline Biomedical AB Company Details
        7.9.2 Corline Biomedical AB Business Overview
        7.9.3 Corline Biomedical AB Cell Regeneration Medicine Introduction
        7.9.4 Corline Biomedical AB Revenue in Cell Regeneration Medicine Business (2017-2022)
        7.9.5 Corline Biomedical AB Recent Development

 8 Research Findings and Conclusion

 9 Appendix
    9.1 Research Methodology
        9.1.1 Methodology/Research Approach
        9.1.2 Data Source
    9.2 Author Details
    9.3 Disclaimer

List of Tables
    Table 1. Cell Regeneration Medicine Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Cell Regeneration Medicine Market Trends
    Table 3. Cell Regeneration Medicine Market Drivers
    Table 4. Cell Regeneration Medicine Market Challenges
    Table 5. Cell Regeneration Medicine Market Restraints
    Table 6. Global Cell Regeneration Medicine Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Cell Regeneration Medicine Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Cell Regeneration Medicine Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Cell Regeneration Medicine Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Cell Regeneration Medicine Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Cell Regeneration Medicine Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Cell Regeneration Medicine Revenue Share by Player, 2017-2022
    Table 13. Global Cell Regeneration Medicine Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Cell Regeneration Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell Regeneration Medicine as of 2021)
    Table 15. Top Players of Cell Regeneration Medicine in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Cell Regeneration Medicine Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Cell Regeneration Medicine Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Cell Regeneration Medicine Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Cell Regeneration Medicine Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Cell Regeneration Medicine Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Cell Regeneration Medicine Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Cell Regeneration Medicine Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Cell Regeneration Medicine Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Cell Regeneration Medicine Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Cell Regeneration Medicine Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Cell Regeneration Medicine Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Cell Regeneration Medicine Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Cell Regeneration Medicine Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Abbott Company Details
    Table 31. Abbott Business Overview
    Table 32. Abbott Cell Regeneration Medicine Product
    Table 33. Abbott Revenue in Cell Regeneration Medicine Business (2017-2022) & (US$ Million)
    Table 34. Abbott Recent Development
    Table 35. Amgen Inc. Company Details
    Table 36. Amgen Inc. Business Overview
    Table 37. Amgen Inc. Cell Regeneration Medicine Product
    Table 38. Amgen Inc. Revenue in Cell Regeneration Medicine Business (2017-2022) & (US$ Million)
    Table 39. Amgen Inc. Recent Development
    Table 40. Astellas Pharma, Inc. Company Details
    Table 41. Astellas Pharma, Inc. Business Overview
    Table 42. Astellas Pharma, Inc. Cell Regeneration Medicine Product
    Table 43. Astellas Pharma, Inc. Revenue in Cell Regeneration Medicine Business (2017-2022) & (US$ Million)
    Table 44. Astellas Pharma, Inc. Recent Development
    Table 45. AstraZeneca plc Company Details
    Table 46. AstraZeneca plc Business Overview
    Table 47. AstraZeneca plc Cell Regeneration Medicine Product
    Table 48. AstraZeneca plc Revenue in Cell Regeneration Medicine Business (2017-2022) & (US$ Million)
    Table 49. AstraZeneca plc Recent Development
    Table 50. Baxter International, Inc. Company Details
    Table 51. Baxter International, Inc. Business Overview
    Table 52. Baxter International, Inc. Cell Regeneration Medicine Product
    Table 53. Baxter International, Inc. Revenue in Cell Regeneration Medicine Business (2017-2022) & (US$ Million)
    Table 54. Baxter International, Inc. Recent Development
    Table 55. Bayer AG Company Details
    Table 56. Bayer AG Business Overview
    Table 57. Bayer AG Cell Regeneration Medicine Product
    Table 58. Bayer AG Revenue in Cell Regeneration Medicine Business (2017-2022) & (US$ Million)
    Table 59. Bayer AG Recent Development
    Table 60. Boehringer Ingelheim Company Details
    Table 61. Boehringer Ingelheim Business Overview
    Table 62. Boehringer Ingelheim Cell Regeneration Medicine Product
    Table 63. Boehringer Ingelheim Revenue in Cell Regeneration Medicine Business (2017-2022) & (US$ Million)
    Table 64. Boehringer Ingelheim Recent Development
    Table 65. Bristol-Myers Squibb Company Details
    Table 66. Bristol-Myers Squibb Business Overview
    Table 67. Bristol-Myers Squibb Cell Regeneration Medicine Product
    Table 68. Bristol-Myers Squibb Revenue in Cell Regeneration Medicine Business (2017-2022) & (US$ Million)
    Table 69. Bristol-Myers Squibb Recent Development
    Table 70. Corline Biomedical AB Company Details
    Table 71. Corline Biomedical AB Business Overview
    Table 72. Corline Biomedical AB Cell Regeneration Medicine Product
    Table 73. Corline Biomedical AB Revenue in Cell Regeneration Medicine Business (2017-2022) & (US$ Million)
    Table 74. Corline Biomedical AB Recent Development
    Table 75. Research Programs/Design for This Report
    Table 76. Key Data Information from Secondary Sources
    Table 77. Key Data Information from Primary Sources
List of Figures
    Figure 1. Cell Regeneration Medicine Product Picture
    Figure 2. Global Cell Regeneration Medicine Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Cell Regeneration Medicine Market Size 2017-2028 (US$ Million)
    Figure 4. United States Cell Regeneration Medicine Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Cell Regeneration Medicine Market Size 2017-2028 (US$ Million)
    Figure 6. United States Cell Regeneration Medicine Market Share in Global 2017-2028
    Figure 7. Cell Regeneration Medicine Report Years Considered
    Figure 8. Product Picture of Primary Cell-based Therapeutics
    Figure 9. Product Picture of Stem Cell & Progenitor Cell-based Therapeutics
    Figure 10. Product Picture of Cell-based Immunotherapies
    Figure 11. Product Picture of Gene Therapies
    Figure 12. Global Cell Regeneration Medicine Market Share by Type in 2022 & 2028
    Figure 13. Global Cell Regeneration Medicine Market Size by Type (2017-2028) & (US$ Million)
    Figure 14. Global Cell Regeneration Medicine Market Share by Type (2017-2028)
    Figure 15. United States Cell Regeneration Medicine Market Share by Type in 2022 & 2028
    Figure 16. United States Cell Regeneration Medicine Market Size by Type (2017-2028) & (US$ Million)
    Figure 17. United States Cell Regeneration Medicine Market Share by Type (2017-2028)
    Figure 18. Product Picture of Dermatology
    Figure 19. Product Picture of Musculoskeletal
    Figure 20. Product Picture of Immunology and Inflammation
    Figure 21. Product Picture of Oncology
    Figure 22. Product Picture of Cardiovascular
    Figure 23. Product Picture of Ophthalmology
    Figure 24. Product Picture of Other Therapeutic Categories
    Figure 25. Global Cell Regeneration Medicine Market Share by Application in 2022 & 2028
    Figure 26. Global Cell Regeneration Medicine Market Size by Application (2017-2028) & (US$ Million)
    Figure 27. Global Cell Regeneration Medicine Market Share by Application (2017-2028)
    Figure 28. United States Cell Regeneration Medicine Market Share by Application in 2022 & 2028
    Figure 29. United States Cell Regeneration Medicine Market Size by Application (2017-2028) & (US$ Million)
    Figure 30. United States Cell Regeneration Medicine Market Share by Application (2017-2028)
    Figure 31. North America Cell Regeneration Medicine Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 32. United States Cell Regeneration Medicine Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. Canada Cell Regeneration Medicine Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. Europe Cell Regeneration Medicine Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 35. Germany Cell Regeneration Medicine Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. France Cell Regeneration Medicine Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. U.K. Cell Regeneration Medicine Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. Italy Cell Regeneration Medicine Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. Russia Cell Regeneration Medicine Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. Asia-Pacific Cell Regeneration Medicine Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 41. China Cell Regeneration Medicine Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Japan Cell Regeneration Medicine Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. South Korea Cell Regeneration Medicine Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. India Cell Regeneration Medicine Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Australia Cell Regeneration Medicine Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. China Taiwan Cell Regeneration Medicine Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Indonesia Cell Regeneration Medicine Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Thailand Cell Regeneration Medicine Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Malaysia Cell Regeneration Medicine Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Latin America Cell Regeneration Medicine Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 51. Mexico Cell Regeneration Medicine Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Brazil Cell Regeneration Medicine Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Argentina Cell Regeneration Medicine Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Middle East & Africa Cell Regeneration Medicine Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 55. Turkey Cell Regeneration Medicine Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 56. Saudi Arabia Cell Regeneration Medicine Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 57. UAE Cell Regeneration Medicine Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Abbott Revenue Growth Rate in Cell Regeneration Medicine Business (2017-2022)
    Figure 59. Amgen Inc. Revenue Growth Rate in Cell Regeneration Medicine Business (2017-2022)
    Figure 60. Astellas Pharma, Inc. Revenue Growth Rate in Cell Regeneration Medicine Business (2017-2022)
    Figure 61. AstraZeneca plc Revenue Growth Rate in Cell Regeneration Medicine Business (2017-2022)
    Figure 62. Baxter International, Inc. Revenue Growth Rate in Cell Regeneration Medicine Business (2017-2022)
    Figure 63. Bayer AG Revenue Growth Rate in Cell Regeneration Medicine Business (2017-2022)
    Figure 64. Boehringer Ingelheim Revenue Growth Rate in Cell Regeneration Medicine Business (2017-2022)
    Figure 65. Bristol-Myers Squibb Revenue Growth Rate in Cell Regeneration Medicine Business (2017-2022)
    Figure 66. Corline Biomedical AB Revenue Growth Rate in Cell Regeneration Medicine Business (2017-2022)
    Figure 67. Bottom-up and Top-down Approaches for This Report
    Figure 68. Data Triangulation
    Figure 69. Key Executives Interviewed

Market Analysis and Insights: Global and United States Cell Regeneration Medicine Market
This report focuses on global and United States Cell Regeneration Medicine market, also covers the segmentation data of other regions in regional level and county level.

Due to the COVID-19 pandemic, the global Cell Regeneration Medicine market size is estimated to be worth US$  million in 2022 and is forecast to a readjusted size of US$  million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, Primary Cell-based Therapeutics accounting for % of the Cell Regeneration Medicine global market in 2021, is projected to value US$  million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Dermatology was the leading segment, accounting for over  percent market share in 2021, and altered to an  % CAGR throughout this forecast period.

In United States the Cell Regeneration Medicine market size is expected to grow from US$  million in 2021 to US$  million by 2028, at a CAGR of % during the forecast period 2022-2028.

Global Cell Regeneration Medicine Scope and Market Size
Cell Regeneration Medicine market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Cell Regeneration Medicine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Cell Regeneration Medicine market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type
    Primary Cell-based Therapeutics
    Stem Cell & Progenitor Cell-based Therapeutics
    Cell-based Immunotherapies
    Gene Therapies

Segment by Application
    Dermatology
    Musculoskeletal
    Immunology and Inflammation
    Oncology
    Cardiovascular
    Ophthalmology
    Other Therapeutic Categories

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        China Taiwan
        Indonesia
        Thailand
        Malaysia
    Latin America
        Mexico
        Brazil
        Argentina
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE

By Company
    Abbott
    Amgen Inc.
    Astellas Pharma, Inc.
    AstraZeneca plc
    Baxter International, Inc.
    Bayer AG
    Boehringer Ingelheim
    Bristol-Myers Squibb
    Corline Biomedical AB